<DOC>
	<DOCNO>NCT00150566</DOCNO>
	<brief_summary>The purpose study test well high dos lanthanum carbonate reduce pre-dialysis level serum phosphorus subject undergoing dialysis due end stage renal disease .</brief_summary>
	<brief_title>Efficacy Safety Lanthanum Controlling Serum Phosphate Levels Subjects With End Stage Renal Disease Who Require Treatment High Levels Phosphate Their Blood</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Subjects ESRD currently require treatment hyperphosphatemia Women childbearing potential must negative serum beta HCG pregnancy test must agree abstain sexual activity use acceptable contraceptive time inform consent throughout study Treatment compound contain calcium , aluminum magnesium use phosphate binder Hypocalcaemia Treatmentnaive phosphate binder serum phosphorus &lt; 5.5 mg/dL Any significant gastrointestinal surgery gastrointestinal disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>